000 | 04827nam a22003735i 4500 | ||
---|---|---|---|
001 | 278373 | ||
003 | MX-SnUAN | ||
005 | 20160429153901.0 | ||
007 | cr nn 008mamaa | ||
008 | 150903s2005 xxu| o |||| 0|eng d | ||
020 |
_a9780387282749 _9978-0-387-28274-9 |
||
024 | 7 |
_a10.1007/0387282742 _2doi |
|
035 | _avtls000330518 | ||
039 | 9 |
_a201509030723 _bVLOAD _c201404120457 _dVLOAD _c201404090239 _dVLOAD _c201401311344 _dstaff _y201401291457 _zstaff _wmsplit0.mrc _x938 |
|
050 | 4 | _aRC254-282 | |
100 | 1 |
_aPass, Harvey I. _eeditor. _9300653 |
|
245 | 1 | 0 |
_aMalignant Mesothelioma : _bAdvances in Pathogenesis, Diagnosis, and Translational Therapies / _cedited by Harvey I. Pass, Nicholas J. Vogelzang, Michele Carbone. |
264 | 1 |
_aNew York, NY : _bSpringer New York, _c2005. |
|
300 |
_aXXVI, 854 páginas, 178 illus. _brecurso en línea. |
||
336 |
_atexto _btxt _2rdacontent |
||
337 |
_acomputadora _bc _2rdamedia |
||
338 |
_arecurso en línea _bcr _2rdacarrier |
||
347 |
_aarchivo de texto _bPDF _2rda |
||
500 | _aSpringer eBooks | ||
505 | 0 | _aCarcinogenesis -- The History of Mesothelioma -- Asbestos-Induced Mesothelioma -- SV40-Mediated Oncogenesis -- Mesothelioma Carcinogenesis: In Vivo Models -- Mesothelial and Mesothelioma Cell Lines -- Molecular Genetics -- Cytogenetics of Malignant Mesothelioma -- Growth Factors and Malignant Mesothelioma -- Oncogenes and Tumor Suppressor Genes in Malignant Mesothelioma -- Angiogenesis and Mesothelioma -- Immune Status and Mesothelioma -- Extracellular Matrix and Mesothelioma: Some Clues to the Invasive Behavior of Mesothelioma -- Genomics and Proteomics in Mesothelioma -- Epidemiology -- Asbestos Mineralogy and Health Effects -- Molecular Epidemiology of Mesothelioma -- Malignant Mesothelioma and Erionite -- Determination of Asbestos Exposure by Pathology and Clinical History -- Mesothelioma and Asbestos Exposure -- From Monkey to Man: The Epidemiologic Evidence of an Association Between Simian Virus 40 and Malignancy -- Causes and Prevention of Technical Artifacts When Studying Simian Virus 40 (SV40) in Human Mesotheliomas -- Molecular Detection of Siman Virus 40 in Human Mesothelioma -- Malignant Mesothelioma Following Radiation -- Genetics and Human Mesothelioma -- Clinical Presentation -- Clinicians’ Approach to Mesothelioma -- Clinical Presentation and Natural History of Mesothelioma: Pleural and Pericardial -- Clinical Presentation and Natural History of Mesothelioma: Abdominal -- Staging of Mesothelioma -- Prognostic Factors in Mesothelioma -- Imaging and Endoscopy -- Radiologic Assessment of Mesothelioma -- Endoscopic Imaging -- Pathology -- Benign Mesotheliomas, Mesothelial Proliferations, and Their Possible Association with Asbestos Exposure -- Cytology of Malignant Mesothelioma -- Immunohistochemistry -- Malignant Mesothelioma Electron Microscopy -- Rare Variants of Mesothelioma -- Differentiating Sarcomas from Mesotheliomas -- Diagnosis of Synovial Sarcoma of the Pleura and Differentiation from Malignant Mesothelioma -- Pitfalls in the Diagnosis of Malignant Mesothelioma -- Treatment -- Management of Benign Variants of Mesothelioma -- First-Line Chemotherapy for Malignant Pleural Mesothelioma -- Second-Line Chemotherapy -- Treatment of Mesothelioma with Radiotherapy -- Multimodality Approaches -- Intrapleural Chemotherapy with and Without Surgery in Malignant Pleural Mesothelioma (MPM) -- Management of Pleural Effusions in Mesothelioma -- Preoperative Chemotherapy and Surgery -- Photodynamic Therapy for Pleural Mesothelioma -- Surgery and Postoperative Radiotherapy -- The Development of the Brigham and Women’s Multimodality Treatment Plan for Malignant Pleural Mesothelioma: A Model for Improving the Treatment of Rare Diseases -- Peritoneal Mesothelioma: The Columbia Experience -- Surgery, Hyperthermic Chemoperfusion, and Postoperative Chemotherapy: The National Cancer Institute and Washington Hospital Center Experience -- Pericardial and Tunica Vaginalis Mesothelioma -- Novel Treatment Strategies -- New Target Therapies for Malignant Mesothelioma -- Gene Therapy for Malignant Pleural Mesothelioma -- Immunotherapeutic Approaches and Vaccination Strategies -- Economic Implications -- Economic Aspects of Mesothelioma. | |
520 | _ano bcc - textbook design | ||
590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
700 | 1 |
_aVogelzang, Nicholas J. _eeditor. _9301975 |
|
700 | 1 |
_aCarbone, Michele. _eeditor. _9301976 |
|
710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
776 | 0 | 8 |
_iEdición impresa: _z9780387229492 |
856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/0-387-28274-2 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 | _c14 | ||
999 |
_c278373 _d278373 |